Table 4:

Association Between Clinical Factors and Postoperative Complications

Variable	No Complication n(%) n = 37 (79%)	Complication (n,%) n = 10 (21%)	P value
Age [mean in years (SD)]	32 (12)	33 (13)	0.79
Female gender [n (%)]	12 (32.4)	4 (40)	0.66
CRP [mean in mg/dL (SD)]	34.7 (30)	49 (54)	0.44
Albumin level [mean (SD)]	3.8 (0.7)	3.7 (0.7)	0.75
Active smoker [n (%)]	1 (2.7)	4 (40)	0.002*
Deep colonic ulcers [n (%)]	14 (37.8)	2 (20)	0.27
Kidney injury [n (%)]	8 (21.6)	0	0.11
aPrior anti-tumor necrosis factor agent use (Anti-TNF) [n (%)]	2 (5.4)	0	0.45
aPrior use of immunomodulators [n (%)]	27 (73)	6 (60)	0.43
aPrior clostridium difficle infection [n (%)]	3 (8.1)	1 (10)	0.85
aPrior cytomegalovirus (CMV) infection [n (%)]	None	3 (30)	0.002*
Days on intravenous steroids before initiation of cyclosporine [mean in days, SD]	4.59 (2.35)	4.25 (2.49)	0.70

_a “Prior” refers to use of anti-TNF agents, immunomodulators, or infection with clostridium difficle or CMV at any time point before IV ciclosporin administration